Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product, Usability Type & Application The global neuroendoscopy devices market size was $186.99 million in 2021 and is predicted to reach $314.31 million by 2030, representing a CAGR of 5.94% throughout the period of 2021-2030.North America held the highest percentage of the market revenue share at around USD 75 million in 2018. Neuroendoscopy is a minimally invasive technique used in brain surgery to remove tumors. A neuroendoscopic camera is guided to the brain with no or minimal scars. Once the camera reaches the brain, the doctor determines the medical issue to be treated. This process causes minimal damage to typical structures and carries a lower risk of complications, faster recovery, and minimal scarring compared to traditional brain surgery. According to a study, the probability of complications arising due to minimally invasive neurosurgery was 12.67%. Market Drivers - Rising Occurrence of Diseases, Increasing Demand for Minimally Invasive Surgical Procedures, and Higher Success Rate The market has grown due to the increased frequency of diseases like osteosarcoma, brain tumour, optic nerve compression, pseudotumour cerebri, nervous system cysts, and other neurovascular disorders. According to ASCO (American Society for Clinical Oncology), 25,050 adults in the USA are estimated to be diagnosed with primary cancerous tumours of the brain and spinal cord in 2022. There is a growing demand for minimally invasive surgical procedures from doctors and patients. Patients feel less postoperative pain and fewer operative and postoperative complications while doctors operate for less time on them. According to MayoClinic, minimally invasive neurosurgery takes 2.5 hours to complete. Thus, Neuroendoscopy is preferred, significantly accelerating industry growth throughout the estimated time. Many patients prefer neuroendoscopy-assisted surgery due to its high success rate. According to a research study that was published in the Journal of Neurosurgery, the success rate of endoscopic third ventriculostomy (ETV) is 78% during long-term follow-up. This high probability of success is helping to drive the market growth extensively. Market Restraints - Lack of Skilled Professionals in Developing Countries, High Costs associated with Surgeries and Devices In developing countries, the limited availability of trained professionals in neuroendoscopy has limited the market’s growth. As per a new study that was published in the Journal of Neurosurgery, approximately 23,300 neurosurgeons were required to treat more than 5 million existing neurosurgical cases. The high costs of devices cause medical institutions to prefer conventional methods, which impedes industry growth. Moreover, the high cost of minimally invasive neurosurgery also forces patients to opt for other treatment options, which hampers the market growth. According to a study in the NCBI, an endoscopic third ventriculostomy costs around USD 2200. Market Opportunities - Advancement in Technology The advancement in neuroendoscopy technology can cause a shift in the neuroendoscopy devices market trends. New techniques using cerebrospinal fluid and a device like Flexible Video-Neuro Endoscope can help develop new methods of neuroendoscopy, which can improve the market growth. Neuroendoscopy surgeries like endoscopic microvascular decompression and endoscopic third ventriculostomy have been used recently. The new surgeries are found to have an excellent success rate. As per a new research study published in the Journal of Neurosurgery, the outcome rates of endoscopic microvascular depression are between 77% to 98%. Market Analysis Of Different Segments Covered in the Report Based on Product Rigid Endoscopes Flexible Endoscopes Based on Application Transnasal Neuroendoscopy Intraventricular neuroendoscopy Transcranial neuroendoscopy Based on Usability Reusable endoscopes Disposable endoscopes Based on the Patient’s Age Adult patient Paediatric patient Based on End-Use Hospitals Ambulatory Surgical Centres Diagnostic Centres Others Regional Coverage Analysis North America United States of America Canada Rest of North America Europe United Kingdom Germany France Russia Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Argentina Rest of Latin America Segments Analysis & Insights Rigid endoscopes have occupied nearly 68% of the total neuroendoscopy devices market share based on the product. Increasing applications of rigid endoscopes in intraventricular neuroendoscopy and emerging novel products in the neuroendoscopy industry have boosted the industry growth. Based on application, transcranial endoscopy is expected to be the fastest-growing market in neuroendoscopy, with a CAGR of around 5%. Improvements in preoperative imaging in transcranial endoscopy have allowed neurosurgeons to plan and treat complicated cases through less invasive procedures. Based on usability, the disposable neuroendoscopes segment is the largest market in neuroendoscopy devices, with a valuation of USD 22 million in 2018. The cost of disposable neuroendoscopes is lower than that of reusable neuroendoscopes. In addition, they limit the threat of infection as they are meant for single use. Disposable neuroendoscopes can be used in developing countries due to their lower costs. The paediatric segment is expected to grow the fastest based on the patient’s age, with a CAGR of 6.5%. The growing number of paediatric tumour cases and the increasing number of skilled paediatric neurosurgeons will drive the industry demand for this segment. According to a study in the NCBI, there are 5.14 cases of brain cancer in the US per 100,000 children below the age of 15 years. Hospitals have captured the largest industry size based on end-user—the revenue share valued at USD 68 million in 2018. State-of-the-art infrastructure, insurance coverage for patients, skilled healthcare professionals and the increasing number of neurosurgeries will help boost the market growth. According to a study in the NCBI, there are currently around 50,000 neurosurgeons worldwide. The number of neurosurgeons is expected to increase to cope with the rising demand for neurosurgery, thus accelerating the market growth in this segment. Based on region, North America has the largest neuroendoscopy devices market share, valuing around USD 75 million in 2018. Governmental and private funding, increasing healthcare expenditure, and technological advances in neuroendoscopes will help the market growth to foster. As per a study that was published in the Journal of Neurosurgery, around 13.8 million people require neurosurgery. The increasing demand for neurosurgery also helped drive industry growth in this segment. Neuroendoscopy Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 186.99 million Revenue forecast in 2030 USD 314.31 million Growth rate CAGR of approximately 5.94% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Million, CAGR (2021 - 2030) Segmentation By Product, By Application, By Usability, By Patient Age, By End-User and By Regions By Product Rigid and Flexible Endoscopes By Application Transnasal, Intraventricular, and Transcranial Neuroendoscopy By Usability Reusable and Disposable Endoscopes By Patient Age Adult and Paediatric Patients By End-User Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Others By Region Asia-Pacific, North America, Europe, LAMEA Country Scope U.S., Canada, France, Germany, U.K., Russia, China, Japan, India, Brazil, Argentina, Mexico etc. Company Usability Profiles Charles River Laboratories International, Inc., The Jackson Laboratory, Laboratory Corporation of America Holdings (Covance), Perkin Elmer (Horizon Discovery Group plc), genOway, Envigo, JANVIER LABS, Taconic Biosciences Inc., Biomedical Research Models (Biomere), Transpogen Biopharmaceutical, Inc. Pricing & purchase options Customized purchase options are available to cater to your exact research needs. Global Neuroendoscopy Devices Market Competitive Landscape Analysis Major companies in this market adopt specific strategies like product launches, mergers and acquisitions and significant investments to boost their portfolio and geographic expansion. The key players in the global industry are: Ackermann Instrumente Schindler Clarus Medical LocaMed Machida Tonglu Wanhe Medical B. Braun Aesculap Karl Storz VisionSense ClearMind Biomedical evonos Recent Developments On August 2022, a group of U.S. scientists figured out that Neuroendoscopy can prove to be one of the best options of treatment for patients suffering from Brain Abscesses and can provide them with remarkable results. Neuroendoscopic treatments for patients suffering from brain abscesses have a plethora of curative effects, fewer complications, and a rapid rate of post-operative recovery as compared to the other type of methods. In September 2021, evonos successfully demonstrated its products evoDrill and evoFrame at the Neuroendoscopy Week 2021 at the Medical Centre of the Saarland University, Homburg-Saar, Germany. Evonos believes that the successful demonstration of its products would help advance neuroendoscopic and neurosurgical fields. In August 2021, adeor medical AG announced its strategic and commercial collaboration with ClearPoint Neuro, Inc. Adeor Medical believes that this partnership will allow it to leverage ClearPoint’s advanced neurological insights to penetrate the US market. In January 2021, ClearMind Biomedical announced the FDA 510 (k) clearance for its neuroendoscope, the Axonpen system. ClearMind believes that the FDA clearance will allow it to assist neurosurgeons in swiftly and effectively treating their patients. In February 2020, Karl Storz announced that it had reversed its decision to withdraw from the neuroendoscopy and spine surgery market. Karl Storz believes that through this decision, it can continue manufacturing and providing neuroendoscopic devices to provide safe and high-quality solutions that care for the patients’ well-being. Various Leading Devices that Key Market Leaders Develop Name of the Product Function Key Players LOTTA Full Range Intraventricular Endoscopic Interventions in Children and Adults Karl Storz MINOP Intraventricular Endoscopic Interventions B. Braun Aesculap Neuroendoscopy MS-1000 Series Endoscopic Assisted Transsphenoidal Approach Machida NEV 0-177-6 and NEV 30-177-6 Minimal invasive cranial endoscopy Adeor NeuroPEN Ventricular Catheter Placement Clarus Medical Frequently Asked Question About This Report How big is the neuroendoscopy market? The global neuroendoscopy market size was $186.99 Mn in 2021 and is predicted to reach $314.31 Mn by 2030, with a CAGR of 5.94%. How much is the global market worth? The global market is currently worth USD 198.12 million. It is projected to grow up to USD 314.44 million by 2030. What is the neuroendoscopy market growth? The global neuroendoscopy market is expected to grow at a compound annual growth rate (CAGR) of 5.94% from 2021 to 2030 to reach USD314.31 million by 2030. What is Neuroendoscopy? Neuroendoscopy is a minimally invasive surgical technique used to remove brain tumours. What is the CAGR of the market? The CAGR of the market is around 5.94%. Sources https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900069/ https://www.cancer.net/cancer-types/brain-tumor/statistics https://www.mayoclinic.org/medical-professionals/neurology-neurosurgery/news/robot-assisted-spinal-surgery-shows-promising-initial-results/mac-20506841 https://www.intechopen.com/chapters/59183 https://www.researchgate.net/publication/324812553_Global_neurosurgery_the_current_capacity_and_deficit_in_the_provision_of_essential_neurosurgical_care_Executive_Summary_of_the_Global_Neurosurgery_Initiative_at_the_Program_in_Global_Surgery_and_Socia https://pubmed.ncbi.nlm.nih.gov/25054985/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Neuroendoscopy Market 4.2.1 Global market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global market, by Region, 2021-2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Global market, By Product Type, 2021-2030 (USD Million) 4.5 By The Patient’s Age Business Analysis 4.5.1 Global market, By The Patient’s Age Type, 2021-2030 (USD Million) 4.6 By Usability Analysis 4.6.1 Global market, By Usability Type, 2021-2030 (USD Million) 4.7 By End Product Business Analysis 4.7.1 Global market, By End Product Type, 2021-2030 (USD Million) 4.8 Application Business Analysis 4.8.1 Global market, By Application, 2021-2030 (USD Million) 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. The Patient’s Age Analysis 5.11.1. Trends in The Patient’s Age (2014-2020) 5.11.2. Trends in The Patient’s Age (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Rigid Endoscopes 7.3.1. Rigid Endoscopes market, 2021-2030 (USD Million) 7.4. Flexible Endoscopes 7.4.1. Flexible Endoscopes market, 2021-2030 (USD Million) 8. Global Market: By The Patient’s Age Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Adult patient 8.3.1. Adult patient market, 2021-2030 (USD Million) 8.4. Paediatric patient 8.4.1. Paediatric patient market, 2021-2030 (USD Million) 9. Global Market: By Usability Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Reusable endoscopes 9.3.1. Reusable endoscopes market, 2021-2030 (USD Million) 9.4. Disposable endoscopes 9.4.1. Disposable endoscopes market, 2021-2030 (USD Million) 10. Global Market: By End Product Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Hospitals 10.3.1. Hospitals market, 2021-2030 (USD Million) 10.4. Ambulatory Surgical Centres 10.4.1. Ambulatory Surgical Centres market, 2021-2030 (USD Million) 10.5 Diagnostic Centres 10.5.1 Diagnostic Centres market, 2021-2030 (USD Million) 11. Global Market: By Application Segment Analysis 11.1. Introduction 11.2. Sales Volume & Revenue Analysis (2021-2030) 11.3. Transnasal 11.3.1. Transnasal market, 2021-2030 (USD Million) 11.4. Transcranial 11.4.1. Transcranial market, 2021-2030 (USD Million) 12. Global Market: Regional Outlook 12.1 North America 12.1.1. North America market, By End Product Type, 2021-2030 (USD Million) 12.1.4. North America market, By Application, 2021-2030 (USD Million) 12.1.5. North America market, by Country, 2021-2030 (USD Million) 12.1.4.1. U.S. 12.1.4.1.1. U.S. market, By End Product Type, 2021-2030 (USD Million) 12.1.4.2. Canada 12.1.4.2.1. Canada market, By End Product Type, 2021-2030 (USD Million) 12.1.4.2.2. Canada market, By Region, 2021-2030 (USD Million) 12.1.4.2.3. Canada market, by Applications, 2021-2030 (USD Million) 12.2. Europe 12.2.1. Europe market, By End Product Type, 2021-2030 (USD Million) 12.2.2. Europe market, by By Application, 2021-2030 (USD Million) 12.2.5. Europe market, by country, 2021-2030 (USD Million) 12.2.4.1 U.K. 12.2.4.1.1. U.K. market, By End Product Type, 2021-2030 (USD Million) 12.2.4.1.2. U.K. market, By Applications, 2021-2030 (USD Million) 12.2.4.1.3. U.K. market, by Region, 2021-2030 (USD Million) 12.2.4.2. Germany 12.2.4.2.1. Germany market, By End Product Type, 2021-2030 (USD Million) 12.2.4.2.2. Germany market, By Application, 2021-2030 (USD Million) 12.2.4.2.3. Germany market, by Region, 2021-2030 (USD Million) 12.2.4.3. France 12.2.4.3.1. France market, By End Product Type, 2021-2030 (USD Million) 12.2.4.3.2. France market, By Region, 2021-2030 (USD Million) 12.2.4.3.3. France market, by Application, 2021-2030 (USD Million) 12.2.4.4. Rest of Europe 12.2.4.4.1. Rest of Europe market, By End Product Type, 2021-2030 (USD Million) 12.2.4.4.2. Rest of Europe market, By Region, 2021-2030 (USD Million) 12.2.4.4.3. Rest of Europe market, by Application, 2021-2030 (USD Million) 12.3. Asia Pacific 12.3.1. Asia Pacific market, By End Product Type, 2021-2030 (USD Million) 12.3.2. Asia Pacific market, By Application, 2021-2030 (USD Million) 12.3.5. Asia Pacific market, by country, 2021-2030 (USD Million) 12.3.4.1. China 12.3.4.1.1. China market, By End Product Type, 2021-2030 (USD Million) 12.3.4.1.2. China market, By Region, 2021-2030 (USD Million) 12.3.4.1.3. China market, by Application, 2021-2030 (USD Million) 12.3.4.2. India 12.3.4.2.1. India market, By End Product Type, 2021-2030 (USD Million) 12.3.4.2.2. India market, By Region, 2021-2030 (USD Million) 12.3.4.2.3. India market, by Application, 2021-2030 (USD Million) 12.3.4.3. Japan 12.3.4.3.1. Japan market, By End Product Type, 2021-2030 (USD Million) 12.3.4.3.3. Japan market, by Application, 2021-2030 (USD Million) 12.3.4.4. South Korea 12.3.4.4.1. South Korea market, By End Product Type, 2021-2030 (USD Million) 12.3.4.4.3. South Korea market, by Application, 2021-2030 (USD Million) 12.3.4.5. Rest of ASIA PACIFIC 12.3.4.5.1. Rest of ASIA PACIFIC market, By End Product Type, 2021-2030 (USD Million) 12.3.4.5.3. Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million) 12.4. Latin America 12.4.1. Latin America market, By End Product Type, 2021-2030 (USD Million) 12.4.3. Latin America market, by Application, 2021-2030 (USD Million) 12.4.4. Latin America market, by country, 2021-2030 (USD Million) 12.4.4.1. Brazil 12.4.4.1.1. Brazil market, By End Product Type, 2021-2030 (USD Million) 12.4.4.1.3. Brazil market, by Application, 2021-2030 (USD Million) 12.4.4.2. Mexico 12.4.4.2.1. Mexico market, By End Product Type, 2021-2030 (USD Million) 12.4.4.2.3. Mexico market, by Application, 2021-2030 (USD Million) 12.4.4.3. Rest of the Latin America 12.4.4.3.1. Rest of the Latin America market, By End Product Type, 2021-2030 (USD Million) 12.4.4.3.3. Rest of the Latin America market, by Application, 2021-2030 (USD Million) 13. Competitive Landscape 13.1 Ackermann Instrumente. 13.1.1. Company overview 13.1.2. Financial performance 13.1.3. Product Portfolio Analysis 13.1.4. Business Strategy & Recent Development 13.2. Schindler. 13.2.1. Company overview 13.2.2. Financial performance 13.2.3. Product Portfolio Analysis 13.2.4. Business Strategy & Recent Development 13.3. Clarus Medical. 13.3.1. Company overview 13.3.2. Financial performance 13.3.3. Product Portfolio Analysis 13.3.4. Business Strategy & Recent Development 13.4. LocaMed. 13.4.1. Company overview 13.4.2. Financial performance 13.4.3. Product Portfolio Analysis 13.4.4. Business Strategy & Recent Development 13.5. Machida. 13.5.1. Company overview 13.5.2. Financial performance 13.5.3. Product Portfolio Analysis 13.5.4. Business Strategy & Recent Development 13.6. Tonglu Wanhe Medical. 13.6.1. Company overview 13.6.2. Financial performance 13.6.3. Product Portfolio Analysis 13.6.4. Business Strategy & Recent Development 13.7. B. Braun Aesulap. 13.7.1. Company overview 13.7.2. Financial performance 13.7.3. Product Portfolio Analysis 13.7.4. Business Strategy & Recent Development 13.8. Karl Storz. 13.8.1. Company overview 13.8.2. Financial performance 13.8.3. Product Portfolio Analysis 13.8.4. Business Strategy & Recent Development 13.9. VisionSense. 13.9.1. Company overview 13.9.2. Financial performance 13.9.3. Product Portfolio Analysis 13.9.4. Business Strategy & Recent Development List of Tables (56 Tables) TABLE 1. MARKET, By Product Type, 2021-2030 (USD Million) TABLE 2. MARKET FOR Rigid Endoscopes, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Flexible Endoscopes, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET, By The Patient’s Age, 2021-2030 (USD Million) TABLE 5. MARKET FOR Adult patient, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Paediatric patient, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET, By Usability Type, 2021-2030 (USD Million) TABLE 8. MARKET FOR Reusable endoscopes, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Disposable endoscopes, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET, By End Product Type, 2021-2030 (USD Million) TABLE 11. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Ambulatory Surgical Centres, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Diagnostic Centres, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Other, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Transnasal , BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Intraventricular , BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Transcranial , BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA MARKET, BY Applications, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, By End Product Type, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. EUROPE MARKET, By End Product Type, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, By End Product Type, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 30. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 31. LAMEA MARKET, By End Product Type, 2021-2030 (USD Million) TABLE 32. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 33. Ackermann Instrumente: COMPANY SNAPSHOT TABLE 34. Ackermann Instrumente: OPERATING SEGMENTS TABLE 35. Schindler: COMPANY SNAPSHOT TABLE 36. Schindler: OPERATING SEGMENTS TABLE 37. Clarus Medical: COMPANY SNAPSHOT TABLE 38. Clarus Medical: OPERATING SEGMENTS TABLE 39. LocaMed: COMPANY SNAPSHOT TABLE 40. LocaMed: OPERATING SEGMENTS TABLE 41. Machida: COMPANY SNAPSHOT TABLE 42. Machida: OPERATING SEGMENTS TABLE 43. Tonglu Wanhe Medical: COMPANY SNAPSHOT TABLE 44. Tonglu Wanhe Medical: OPERATING SEGMENTS TABLE 45. B. Braun Aesulap: COMPANY SNAPSHOT TABLE 46. B. Braun Aesulap: OPERATING SEGMENTS TABLE 47. Karl Storz: COMPANY SNAPSHOT TABLE 48. Karl Storz: OPERATING SEGMENTS TABLE 49. VisionSense: COMPANY SNAPSHOT TABLE 50. VisionSense: OPERATING SEGMENTS List of Figures (26 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Application-Based Estimation Figure 6 Top 9 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for , By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for , By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Product, 2019 vs. 2025 (USD Million) Figure 12 Market, By The Patient’s Age, 2019 vs. 2025 (USD Million) Figure 13 Market, By Usability, 2019 vs. 2025 (USD Million) Figure 14 Market, By End Product, 2019 vs. 2025 (USD Million) Figure 15 Market Share, By Application Type, 2019 vs. 2025 Figure 16 Geographical Snapshot of the Market Figure 17 Rigid Endoscopes to Witness Higher CAGR in the Market for Product Segment during Forecast Period. Figure 18 Paediatric patient to Witness Higher CAGR in the Market for The Patient’s Age Type Segment during Forecast Period. Figure 19 Disposable endoscopes to Witness Higher CAGR in the Market for Usability Type Segment during Forecast Period. Figure 20 Hospitals center to Witness Higher CAGR in the Market for End Product Segment during Forecast Period. Figure 21 Transcranial to Witness Higher CAGR in the Market for Application Segment during Forecast Period. Figure 22 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 23 Market: Drivers, Restraints, Opportunities, and Challenges Figure 24 North America: Market Snapshot Figure 25 Asia Pacific: Market Snapshot Figure 26 Vendor Dive: Evaluation Overview